Solasia Pharma K.K.
Japan - TokyoPharmaceutical
Focus: Solasia Pharma is a Japan-based pharmaceutical company specializing in licensing Western oncology products for distribution and development in Asian markets. The company operates a hybrid model combining in-licensed assets with early-stage internal development programs.
Profile data last refreshed 1h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Solasia Pharma K.K.
AI assessmentNot HiringNo open roles listed right now. Follow Solasia Pharma K.K. to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Clinical Trials (1)
NCT03546985A Trial of Episil® Oral Liquid in Cancer Patients Suffering From Chemotherapy- and/or Radiation-induced Oral Mucositis
N/AHelp build intelligence for Solasia Pharma K.K.
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.